MAD2L2 and focal segmental glomerulosclerosis: Increased levels of mitotic arrest deficient 2-like protein 2 (MAD2B), which regulates metaphase-to-anaphase transition, was also observed in FSGS patients and adriamycin treated mice and associated with podocyte cell cycle re-entry (Bao et al., 2021).